MedTrace Logo

Effectiveness of Candesartan and Telmisartan on Morning Hypertension in Japanese Obese Patients

NCT00288717 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2007-01-11

No results posted yet for this study

Summary

To investigate the effects of Candesartan and Telmisartan on the home blood pressure, glucose and lipid-metabolism in the hypertensive patients with the accumulation of visceral fat by the newly developed Tele-medicine system

Conditions

Interventions

DRUG

Candesartan

DRUG

Telmisartan

Sponsors & Collaborators

  • Non-Profit Organaizaion "LINE"

    collaborator UNKNOWN

  • Saitama Medical University

    lead OTHER

Principal Investigators

  • Hidetomo Nakamoto, MD · Saitama Medical School Department of Renal Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Completion
2007-09-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00288717 on ClinicalTrials.gov